ResMed Inc. logo
RMDResMed Inc.

Is the P/S ratio high or low?

The P/S ratio of 5.27 is 34% below its 5-year average of 7.99, near the low end of its 5-year range (4.54–13.63).

As of Friday, June 26, 2026. 23.75% below its 12-month average of 6.91.

RMD PS Ratio

RMD PS Ratio Chart

5.27
-30.29% 1Y
RMD PS Ratio

RMD Average PS Ratio Chart

RMD PS Ratio

RMD Current vs Average PS Ratio Chart

RMD PS Ratio Metrics

PS RATIO

5.27

PS RATIO AVG TTM

6.91

PS RATIO AVG 3Y

6.72

PS RATIO AVG 5Y

7.81

PS RATIO AVG 10Y

7.39

PS RATIO AVG 15Y

6.40

PS RATIO AVG 20Y

5.79

CURRENT VS TTM AVG

-23.75%

CURRENT VS 3Y AVG

-21.57%

CURRENT VS 5Y AVG

-32.50%

CURRENT VS 10Y AVG

-28.66%

CURRENT VS 15Y AVG

-17.66%

CURRENT VS 20Y AVG

-8.97%

RMD Competitors' PS Ratio

NAMEMARKET CAPPS RATIOTTM3Y5Y
ResMed Inc. (RMD)$28.81B5.276.916.727.81
DexCom, Inc. (DXCM)vs ›$26.82B5.616.349.6613.33
Moderna, Inc. (MRNA)vs ›$26.45B10.616.375.296.89
Biogen Inc. (BIIB)vs ›$31.51B3.042.472.833.11
IQVIA Holdings Inc. (IQV)vs ›$31.58B1.902.072.402.71
Veeva Systems Inc. (VEEV)vs ›$25.68B7.9112.7213.6715.98
Medline Inc. (MDLN)vs ›$31.94B1.071.201.201.20
Zoetis Inc. (ZTS)vs ›$32.06B3.465.938.119.28
Centene Corp. (CNC)vs ›$32.31B0.100.150.220.26
Mettler-Toledo International Inc. (MTD)vs ›$25.24B6.176.786.967.64

P/S vs. its own history

At 5.27, P/S is in its normal range, sitting higher than 51% of its 20-year history.

20-year low

2.70

median

5.21

20-year high

13.63

cheaperricher

Sales Valuation

P/S Ratio

5.27

Market Cap / Annual Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for ResMed Inc. (RMD)?
The P/S ratio for RMD stock is 5.27.
Is ResMed Inc.'s P/S ratio high or low?
The P/S ratio of 5.27 is 34% below its 5-year average of 7.99, near the low end of its 5-year range (4.54–13.63).
What is the TTM average P/S ratio for ResMed Inc. (RMD)?
The TTM average P/S ratio for RMD stock is 6.91.
What is the 3Y average P/S ratio for ResMed Inc. (RMD)?
The 3Y average P/S ratio for RMD stock is 6.72.
What is the 5Y average P/S ratio for ResMed Inc. (RMD)?
The 5Y average P/S ratio for RMD stock is 7.81.
What is the 10Y average P/S ratio for ResMed Inc. (RMD)?
The 10Y average P/S ratio for RMD stock is 7.39.
What is the 15Y average P/S ratio for ResMed Inc. (RMD)?
The 15Y average P/S ratio for RMD stock is 6.40.
What is the 20Y average P/S ratio for ResMed Inc. (RMD)?
The 20Y average P/S ratio for RMD stock is 5.79.

RMD PS Ratio History

DATEPS RATIO
2026-06-255.27
2026-06-245.22
2026-06-235.08
2026-06-225.00
2026-06-185.01
2026-06-174.95
2026-06-165.15
2026-06-155.12
2026-06-125.17
2026-06-115.11
2026-06-105.14
2026-06-095.23
2026-06-085.13
2026-06-055.21
2026-06-045.16
2026-06-034.95
2026-06-024.85
2026-06-014.95
2026-05-295.06
2026-05-285.40
2026-05-275.47
2026-05-265.52
2026-05-225.52
2026-05-215.55
2026-05-205.57
2026-05-195.52
2026-05-185.42
2026-05-155.36
2026-05-145.38
2026-05-135.37
2026-05-125.41
2026-05-115.28
2026-05-085.49
2026-05-075.49
2026-05-065.57
2026-05-055.52
2026-05-045.56
2026-05-015.44
2026-04-305.68
2026-04-295.77
2026-04-285.91
2026-04-276.05
2026-04-245.99
2026-04-235.98
2026-04-226.05
2026-04-216.03
2026-04-206.16
2026-04-176.21
2026-04-166.12
2026-04-156.23
2026-04-146.28
2026-04-136.27
2026-04-106.23
2026-04-096.21
2026-04-086.28
2026-04-076.16
2026-04-066.13
2026-04-026.10
2026-04-016.07
2026-03-316.11
2026-03-305.99
2026-03-276.01
2026-03-266.06
2026-03-256.16
2026-03-246.22
2026-03-236.21
2026-03-206.16
2026-03-196.19
2026-03-186.21
2026-03-176.36
2026-03-166.28
2026-03-136.29
2026-03-126.33
2026-03-116.54
2026-03-106.73
2026-03-096.89
2026-03-066.89
2026-03-056.95
2026-03-047.06
2026-03-037.04
2026-03-027.01
2026-02-276.98
2026-02-267.00
2026-02-256.88
2026-02-246.85
2026-02-237.10
2026-02-207.06
2026-02-196.98
2026-02-187.05
2026-02-176.97
2026-02-136.88
2026-02-126.69
2026-02-117.07
2026-02-107.18
2026-02-097.52
2026-02-067.40
2026-02-057.27
2026-02-047.16
2026-02-036.85
2026-02-026.94
2026-01-307.04
2026-01-297.02
2026-01-287.21
2026-01-277.15
2026-01-267.14
2026-01-237.06
2026-01-227.14
2026-01-217.25
2026-01-207.08
2026-01-167.20
2026-01-157.29
2026-01-147.26
2026-01-137.12
2026-01-127.21
2026-01-097.06
2026-01-087.02
2026-01-076.94
2026-01-066.97
2026-01-056.86
2026-01-026.85
2025-12-316.74
2025-12-306.80
2025-12-296.79
2025-12-266.85
2025-12-246.84
2025-12-236.84
2025-12-226.90
2025-12-196.85
2025-12-186.78
2025-12-176.88
2025-12-166.92
2025-12-157.08
2025-12-127.06
2025-12-117.06
2025-12-107.03
2025-12-096.89
2025-12-086.99
2025-12-057.18
2025-12-047.03
2025-12-037.03
2025-12-027.02
2025-12-016.95
2025-11-287.15
2025-11-267.13
2025-11-257.15
2025-11-247.01
2025-11-217.01
2025-11-206.82
2025-11-196.85
2025-11-186.89
2025-11-176.84
2025-11-146.84
2025-11-137.05
2025-11-127.07
2025-11-117.06
2025-11-106.99
2025-11-077.03
2025-11-066.98
2025-11-056.86
2025-11-046.89
2025-11-036.96
2025-10-316.90
2025-10-307.06
2025-10-297.25
2025-10-287.33
2025-10-277.41
2025-10-247.41
2025-10-237.58
2025-10-227.61
2025-10-217.66
2025-10-207.75
2025-10-177.66
2025-10-167.71
2025-10-157.71
2025-10-147.72
2025-10-137.80
2025-10-107.77
2025-10-097.94
2025-10-088.07
2025-10-078.09
2025-10-068.04
2025-10-037.96
2025-10-027.90
2025-10-017.74
2025-09-307.82
2025-09-297.74
2025-09-267.72
2025-09-257.64
2025-09-247.83
2025-09-237.87
2025-09-227.84
2025-09-197.81
2025-09-187.81
2025-09-177.76
2025-09-167.79
2025-09-157.75
2025-09-127.72
2025-09-117.85
2025-09-107.73
2025-09-097.98
2025-09-087.98
2025-09-057.92
2025-09-047.82
2025-09-037.69
2025-09-027.74
2025-08-297.84
2025-08-287.87
2025-08-278.06
2025-08-268.15
2025-08-258.17
2025-08-228.39
2025-08-218.24
2025-08-208.26
2025-08-198.17
2025-08-188.17
2025-08-158.14
2025-08-148.13
2025-08-138.24
2025-08-128.09
2025-08-118.12
2025-08-088.11
2025-08-078.00
2025-08-068.22
2025-08-058.36
2025-08-048.54
2025-08-018.19
2025-07-317.97
2025-07-308.13
2025-07-298.14
2025-07-288.02
2025-07-258.07
2025-07-248.02
2025-07-238.01
2025-07-227.84
2025-07-217.65
2025-07-187.56
2025-07-177.52
2025-07-167.45
2025-07-157.39
2025-07-147.45
2025-07-117.46
2025-07-107.57
2025-07-097.50
2025-07-087.52
2025-07-077.52
2025-07-037.53
2025-07-027.50
2025-07-017.51
2025-06-307.56
2025-06-277.48
2025-06-267.51
2025-06-257.56
2025-06-247.50
2025-06-237.46
2025-06-207.44
2025-06-187.36
2025-06-177.33
2025-06-167.38
2025-06-137.31
2025-06-127.39

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA
9,980 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael J. Farrell